GUSBP17

Across TCGA pan-cancer cohorts, GUSBP17 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated GUSBP17 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GUSBP17 RNA is associated with better overall survival. In most high-consensus cancer types, elevated GUSBP17 expression acts as an unfavorable survival marker, although some lineages such as OV and UCS show a favorable association.

OV, UCEC, and UVM are the cancer types where GUSBP17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	All	0.872	0.823	<.001	54	view →
UCEC	DFS	Tertile	All	0.208	0.661	<.001	54	view →
UVM	OS	Tertile	All	0.136	0.919	<.001	45	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.675	<.001	36	view →
LAML	DFS	Quartile	All	0.187	0.517	.012	28	view →
THCA	OS	Tertile	All	0.941	0.993	.016	27	view →
LUSC	OS	Tertile	II,III,IV	0.158	0.422	.014	21	view →
KICH	DFS	Tertile	III,IV	0.035	0.772	.021	18	view →
UCS	OS	Tertile	III,IV	1.000	0.312	.048	18	view →
READ	OS	Tertile	III,IV	0.328	0.750	.012	18	view →
KIRP	DFS	Tertile	All	0.802	0.928	.006	9	view →
BLCA	DFS	Tertile	III,IV	0.699	0.444	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

GUSBP17–OV (OS)

Open the OV breakdown →